Fintel reports that on February 20, 2025, B. Riley Securities initiated coverage of Electromed (NYSEAM:ELMD) with a Buy ...

B. Riley analyst Kyle Bauser initiated coverage of Electromed (ELMD) with a Buy rating and $38 price target Electromed is a profitable, ...

Electromed (EMED) stock was launched by B. Riley with a Buy recommendation, based on its potential to become a takeover target. Read more here.

StockNews.com lowered shares of Electromed (NYSE:ELMD – Free Report) from a strong-buy rating to a buy rating in a report issued on Wednesday morning. Electromed Stock Performance NYSE ELMD opened at ...

Kathleen Skarvan, a director at Electromed, Inc. (NYSE:ELMD), recently reported significant stock transactions involving the company's common stock. The transactions come as the stock has shown ...

Good afternoon, and welcome to the Electromed Second Quarter 2025 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note, this event is being ...

Electromed Inc (ELMD) reported record revenues of $16.3 million for the ninth consecutive quarter of year-over-year growth.

Lake Street analyst Brooks O’Neil maintained a Buy rating on Electromed (ELMD – Research Report) today and set a price target of $36.00. The ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Electromed, Inc. (NYSEMKT:ELMD) engages in the manufacturing of airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care.

Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results ...